Clinical pharmacist‐led costs optimization in ischaemic stroke care: A diagnosis‐related groups‐based intervention study

This study aimed to evaluate the impact of clinical pharmacists' intervention on drug cost optimization for ischaemic stroke inpatients under the diagnosis-related groups (DRGs) payment model. This study collected hospitalization data of patients with ischaemic stroke in the BR23 disease group...

Full description

Saved in:

Bibliographic Details
Published in:	British journal of clinical pharmacology Vol. 91; no. 12; p. 3529
Main Authors:	Li, Yun, Li, Xianlin, Guo, Haitao, Zhang, Jin, Zheng, Xiaojun
Format:	Journal Article
Language:	English
Published:	England 21.08.2025
Subjects:	Aged Aged, 80 and over Diagnosis-Related Groups - economics Drug Costs - statistics & numerical data Drug-Related Side Effects and Adverse Reactions - economics Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - prevention & control Female Hospitalization - economics Hospitalization - statistics & numerical data Humans Ischemic Stroke - drug therapy Ischemic Stroke - economics Length of Stay - economics Length of Stay - statistics & numerical data Male Middle Aged Pharmacists - economics Pharmacists - organization & administration Pharmacy Service, Hospital - economics Pharmacy Service, Hospital - organization & administration Professional Role cost control clinical pathways pharmacists neurology diagnosis‐related groups
ISSN:	0306-5251, 1365-2125, 1365-2125
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!